On a recent episode of Wharton Digital Health’s The Pulse podcast, Hims & Hers Founder and CEO Andrew Dudum discussed a wide range of topics including how Hims & Hers disrupted the $4 trillion healthcare industry by creating a telehealth tool that makes Americans’ medical...
McKesson Corporation today announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer. Building on McKesson’s long history in community oncology, Ontada combines its real-world data and research capabilities...
Clinical Ink, a global clinical trial technology company, today announced an investment from McKesson Ventures, along with its significantly enhanced electronic patient reported outcome (ePRO) module. “McKesson Ventures is excited to invest in Clinical Ink, a market leader in clinical trial enablement technology,” said Dave Schulte,...
McKesson Ventures has hired Michelle Snyder as its newest investment partner. Snyder, a mobile health pioneer, is known for her leadership and guidance in building Epocrates, one of the healthcare industry’s first successful mobile health companies. She brings more than 25 years of healthcare experience to...
In a recent episode of the American Journal of Managed Care’s Managed Care Cast podcast, Dr. Patricia Salber, MD, MBA, of The Doctor Weighs In interviewed Aledade Co-founder and CEO Farzad Mostashari, MD, about how his company is keeping physicians independent through value-based care. Value-based care,...
Kyruus announced that Baptist Health, the largest nonprofit health system in Kentucky, has engaged the company to help elevate its digital access experience for consumers. The health system will collaborate with Kyruus to modernize the care search experience for consumers on the Baptist Health website...
The promise of digital health, telehealth, and other medtech solutions like remote patient monitoring has been apparent to people in the industry for a long time, but it wasn’t until COVID-19 forced the adoption of these tools that the promise started to become a reality. Global...
Vineti, a cloud software startup that manages the development of drugs such as cancer vaccines and cell and gene therapies recently raised a $33 million extension to its Series C round. Business Insider recently interviewed Vineti CEO and Co-founder Amy DuRoss about the company, why...
IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions such as rheumatoid arthritis, multiple sclerosis, and Crohn’s disease, announced its acquisition of Precision Healthcare. Precision operates 12 infusion centers across Tennessee and northern Arkansas. The acquisition was led by...
Vineti, a leading digital platform of record for personalized therapeutics, announced the closing of a $33 million extension to its Series C financing round. The new financing will support further expansion of the company’s Personalized Therapy Management (PTM)® platform for personalized and high-value advanced therapies. The...